Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (161-170 of 668) with videos related to

Pageof 67
Sort By:
Inflammatory Bowel Diseases|November 22, 2019
Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease"María José Casanova, María Chaparro, Javier P Gisbert
Journal of Crohn'S & Colitis|July 18, 2013
Angiopoietins in inflammation and their implication in the development of inflammatory bowel disease. A reviewPablo M Linares, María Chaparro, Javier P Gisbert
Gastroenterology|January 11, 2014
Reply: To PMID 23562754Javier Molina-Infante, Marco Romano, Javier P Gisbert
Helicobacter|December 6, 2007
Evolution of Helicobacter pylori therapy from a meta-analytical perspectiveJavier P Gisbert, Ramón Pajares, José María Pajares
Inflammatory Bowel Diseases|April 14, 2009
Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel diseaseJavier P Gisbert, Adrian G McNicholl, Fernando Gomollon
The American Journal of Gastroenterology|September 25, 2025
Response to Borras-Blasco et alMaría José García, Javier P Gisbert, María Chaparro
Alimentary Pharmacology & Therapeutics|April 23, 2024
Editorial: Sequencing rescue therapy for acute severe ulcerative colitis-Ready for revision? Authors' replyMaría José García, Javier P Gisbert, María Chaparro
The American Journal of Gastroenterology|March 23, 2016
The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-AnalysisJavier P Gisbert, Alicia C Marín, María Chaparro
Alimentary Pharmacology & Therapeutics|January 19, 2026
Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection-Questions Focused on Clinical PracticeJavier P Gisbert, Pablo Parra, Olga P Nyssen
Helicobacter|January 7, 2026
Non-Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication: A Systematic Review and Meta-AnalysisPablo Parra, Olga P Nyssen, Javier P Gisbert
Pageof 67

Showing results (161-170 of 668) with videos related to

Sort By:
Pageof 67
Inflammatory Bowel Diseases|November 22, 2019
Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease"María José Casanova, María Chaparro, Javier P Gisbert
Journal of Crohn'S & Colitis|July 18, 2013
Angiopoietins in inflammation and their implication in the development of inflammatory bowel disease. A reviewPablo M Linares, María Chaparro, Javier P Gisbert
Gastroenterology|January 11, 2014
Reply: To PMID 23562754Javier Molina-Infante, Marco Romano, Javier P Gisbert
Helicobacter|December 6, 2007
Evolution of Helicobacter pylori therapy from a meta-analytical perspectiveJavier P Gisbert, Ramón Pajares, José María Pajares
Inflammatory Bowel Diseases|April 14, 2009
Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel diseaseJavier P Gisbert, Adrian G McNicholl, Fernando Gomollon
The American Journal of Gastroenterology|September 25, 2025
Response to Borras-Blasco et alMaría José García, Javier P Gisbert, María Chaparro
Alimentary Pharmacology & Therapeutics|April 23, 2024
Editorial: Sequencing rescue therapy for acute severe ulcerative colitis-Ready for revision? Authors' replyMaría José García, Javier P Gisbert, María Chaparro
The American Journal of Gastroenterology|March 23, 2016
The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-AnalysisJavier P Gisbert, Alicia C Marín, María Chaparro
Alimentary Pharmacology & Therapeutics|January 19, 2026
Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection-Questions Focused on Clinical PracticeJavier P Gisbert, Pablo Parra, Olga P Nyssen
Helicobacter|January 7, 2026
Non-Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication: A Systematic Review and Meta-AnalysisPablo Parra, Olga P Nyssen, Javier P Gisbert
Pageof 67